166 related articles for article (PubMed ID: 18401866)
21. Free and N-(2-hydroxypropyl)methacrylamide copolymer-bound geldanamycin derivative induce different stress responses in A2780 human ovarian carcinoma cells.
Nishiyama N; Nori A; Malugin A; Kasuya Y; Kopecková P; Kopecek J
Cancer Res; 2003 Nov; 63(22):7876-82. PubMed ID: 14633716
[TBL] [Abstract][Full Text] [Related]
22. Identification of peptide fragments generated by digestion of bovine and human osteocalcin with the lysosomal proteinases cathepsin B, D, L, H, and S.
Baumgrass R; Williamson MK; Price PA
J Bone Miner Res; 1997 Mar; 12(3):447-55. PubMed ID: 9076588
[TBL] [Abstract][Full Text] [Related]
23. Noninvasive visualization of pharmacokinetics, biodistribution and tumor targeting of poly[N-(2-hydroxypropyl)methacrylamide] in mice using contrast enhanced MRI.
Wang Y; Ye F; Jeong EK; Sun Y; Parker DL; Lu ZR
Pharm Res; 2007 Jun; 24(6):1208-16. PubMed ID: 17387601
[TBL] [Abstract][Full Text] [Related]
24. HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. II. Processing in epithelial ovarian carcinoma cells in vitro.
Omelyanenko V; Gentry C; Kopecková P; Kopecek J
Int J Cancer; 1998 Feb; 75(4):600-8. PubMed ID: 9466663
[TBL] [Abstract][Full Text] [Related]
25. HPMA copolymer-1,5-diazaanthraquinone conjugates as novel anticancer therapeutics.
Vicent MJ; Manzanaro S; de la Fuente JA; Duncan R
J Drug Target; 2004; 12(8):503-15. PubMed ID: 15621676
[TBL] [Abstract][Full Text] [Related]
26. Star structure of antibody-targeted HPMA copolymer-bound doxorubicin: a novel type of polymeric conjugate for targeted drug delivery with potent antitumor effect.
Kovár M; Strohalm J; Etrych T; Ulbrich K; Ríhová B
Bioconjug Chem; 2002; 13(2):206-15. PubMed ID: 11906257
[TBL] [Abstract][Full Text] [Related]
27. Semitelechelic HPMA copolymers functionalized with triphenylphosphonium as drug carriers for membrane transduction and mitochondrial localization.
Callahan J; Kopecek J
Biomacromolecules; 2006 Aug; 7(8):2347-56. PubMed ID: 16903681
[TBL] [Abstract][Full Text] [Related]
28. Proteolytic excision of a repressive loop domain in tartrate-resistant acid phosphatase by cathepsin K in osteoclasts.
Ljusberg J; Wang Y; Lång P; Norgård M; Dodds R; Hultenby K; Ek-Rylander B; Andersson G
J Biol Chem; 2005 Aug; 280(31):28370-81. PubMed ID: 15929988
[TBL] [Abstract][Full Text] [Related]
29. Star-shaped immunoglobulin-containing HPMA-based conjugates with doxorubicin for cancer therapy.
Etrych T; Mrkvan T; Ríhová B; Ulbrich K
J Control Release; 2007 Sep; 122(1):31-8. PubMed ID: 17631976
[TBL] [Abstract][Full Text] [Related]
30. Cathepsins in the osteoclast.
Goto T; Yamaza T; Tanaka T
J Electron Microsc (Tokyo); 2003; 52(6):551-8. PubMed ID: 14756243
[TBL] [Abstract][Full Text] [Related]
31. Localization of rat cathepsin K in osteoclasts and resorption pits: inhibition of bone resorption and cathepsin K-activity by peptidyl vinyl sulfones.
Xia L; Kilb J; Wex H; Li Z; Lipyansky A; Breuil V; Stein L; Palmer JT; Dempster DW; Brömme D
Biol Chem; 1999 Jun; 380(6):679-87. PubMed ID: 10430032
[TBL] [Abstract][Full Text] [Related]
32. Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency.
Gelb BD; Shi GP; Chapman HA; Desnick RJ
Science; 1996 Aug; 273(5279):1236-8. PubMed ID: 8703060
[TBL] [Abstract][Full Text] [Related]
33. Immunocytochemical localization of cathepsins B and G in odontoclasts of human deciduous teeth.
Sasaki T; Ueno-Matsuda E
J Dent Res; 1992 Dec; 71(12):1881-4. PubMed ID: 1452887
[TBL] [Abstract][Full Text] [Related]
34. Water-soluble polymers for targeted drug delivery to human squamous carcinoma of head and neck.
Nan A; Ghandehari H; Hebert C; Siavash H; Nikitakis N; Reynolds M; Sauk JJ
J Drug Target; 2005 Apr; 13(3):189-97. PubMed ID: 16036307
[TBL] [Abstract][Full Text] [Related]
35. Breast cancer cells express cathepsins B and L but not cathepsins K or H.
Ishibashi O; Mori Y; Kurokawa T; Kumegawa M
Cancer Biochem Biophys; 1999 Jul; 17(1-2):69-78. PubMed ID: 10738903
[TBL] [Abstract][Full Text] [Related]
36. Intracellularly biorecognizable derivatives of 5-fluorouracil. Implications for site-specific delivery in the human condition.
Putnam DA; Shiah JG; Kopecek J
Biochem Pharmacol; 1996 Sep; 52(6):957-62. PubMed ID: 8781516
[TBL] [Abstract][Full Text] [Related]
37. Doxorubicin-loaded, charge reversible, folate modified HPMA copolymer conjugates for active cancer cell targeting.
Li L; Yang Q; Zhou Z; Zhong J; Huang Y
Biomaterials; 2014 Jun; 35(19):5171-87. PubMed ID: 24702960
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of protein-N-(2-hydroxypropyl)methacrylamide copolymer conjugates as targetable drug carriers. 1. Binding, pinocytic uptake and intracellular distribution of transferrin and anti-transferrin receptor antibody conjugates.
Flanagan PA; Kopecková P; Kopecek J; Duncan R
Biochim Biophys Acta; 1989 Oct; 993(1):83-91. PubMed ID: 2804126
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of cathepsin K accelerates the resorption cycle and osteoblast differentiation in vitro.
Morko J; Kiviranta R; Mulari MT; Ivaska KK; Väänänen HK; Vuorio E; Laitala-Leinonen T
Bone; 2009 Apr; 44(4):717-28. PubMed ID: 19118660
[TBL] [Abstract][Full Text] [Related]
40. Lysosomal processing of amyloid precursor protein to A beta peptides: a distinct role for cathepsin S.
Munger JS; Haass C; Lemere CA; Shi GP; Wong WS; Teplow DB; Selkoe DJ; Chapman HA
Biochem J; 1995 Oct; 311 ( Pt 1)(Pt 1):299-305. PubMed ID: 7575468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
